Megan Kelly is a Partner at Threshold Ventures where she invests in early-stage startups across Enterprise Technology, Healthcare Technology, Consumer Technology, AI, and SaaS. She invests in companies in the United States, including the Greater New York Area and the East Coast. She serves on the board of M7 Health and is a board observer at QA Wolf, ODAIA, and Vital, and has invested in M7 Health, QA Wolf, ODAIA, and Vital. Before Threshold, she was an Investor at First Round Capital; earlier, she was Chief of Staff at Thrive Global and held roles at J.P. Morgan including Investor – FIG, Business Management and Strategy Associate, and Business Management and Strategy Analyst. Megan graduated from the College of the Holy Cross and lives in New York.